These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 12048279)

  • 1. Re: All-cause mortality in randomized trials of cancer screening.
    Begg CB; Bach PB
    J Natl Cancer Inst; 2002 Jun; 94(11):863-4; author reply 865-6. PubMed ID: 12048279
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: All-cause mortality in randomized trials of cancer screening.
    Church TR; Ederer F; Mandel JS
    J Natl Cancer Inst; 2002 Jun; 94(11):861; author reply 865-6. PubMed ID: 12048277
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: All-cause mortality in randomized trials of cancer screening.
    Weiss NS; Koepsell TD
    J Natl Cancer Inst; 2002 Jun; 94(11):864-5; author reply 865-6. PubMed ID: 12048281
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: All-cause mortality in randomized trials of cancer screening.
    Kopans DB; Halpern E
    J Natl Cancer Inst; 2002 Jun; 94(11):863; author reply 865-6. PubMed ID: 12048280
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: All-cause mortality in randomized trials of cancer screening.
    Parker C; Dearnaley D
    J Natl Cancer Inst; 2002 Jun; 94(11):861-2; author reply 865-6. PubMed ID: 12048276
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: All-cause mortality in randomized trials of cancer screening.
    Gail MH; Katki HA
    J Natl Cancer Inst; 2002 Jun; 94(11):862; author reply 865-6. PubMed ID: 12048278
    [No Abstract]   [Full Text] [Related]  

  • 7. Hemoccult should no longer be used for the screening of colorectal cancer.
    Bleiberg H
    Ann Oncol; 2002 Jan; 13(1):44-6. PubMed ID: 11863109
    [No Abstract]   [Full Text] [Related]  

  • 8. All-cause mortality in randomized trials of cancer screening.
    Black WC; Haggstrom DA; Welch HG
    J Natl Cancer Inst; 2002 Feb; 94(3):167-73. PubMed ID: 11830606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reanalysis of All-Cause Mortality in the U.S. Preventive Services Task Force 2016 Evidence Report on Colorectal Cancer Screening.
    Swartz AW; Eberth JM; Josey MJ; Strayer SM
    Ann Intern Med; 2017 Oct; 167(8):602-603. PubMed ID: 28828493
    [No Abstract]   [Full Text] [Related]  

  • 10. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood.
    Mandel JS; Church TR; Ederer F; Bond JH
    J Natl Cancer Inst; 1999 Mar; 91(5):434-7. PubMed ID: 10070942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for rectal cancer.
    St John DJ
    Hepatogastroenterology; 2000; 47(32):305-9. PubMed ID: 10791177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Too early to recommend universal screening for colorectal cancer].
    Ekelund G; Janzon L
    Lakartidningen; 2003 Sep; 100(38):2922-6. PubMed ID: 14558210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sigmoidoscopy screening probably works, but how well is still unknown.
    Mandel JS
    J Natl Cancer Inst; 2003 Apr; 95(8):571-3. PubMed ID: 12697843
    [No Abstract]   [Full Text] [Related]  

  • 14. Screening for colorectal cancer--which strategy is the best?
    Church TR
    J Natl Cancer Inst; 2011 Sep; 103(17):1282-3. PubMed ID: 21852265
    [No Abstract]   [Full Text] [Related]  

  • 15. A data-analytic approach for estimating lead time and screening benefit based on survival curves in randomized cancer screening trials.
    Kafadar K; Prorok PC
    Stat Med; 1994 Mar 15-Apr 15; 13(5-7):569-86. PubMed ID: 8023036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recommendation to include colorectal cancer screening in public health policy. The European Group for Colorectal Cancer Screening.
    J Med Screen; 1999; 6(2):80-1. PubMed ID: 10444725
    [No Abstract]   [Full Text] [Related]  

  • 17. Colorectal cancer screening.
    Ederer F; Church T; Mandel J
    Scand J Gastroenterol; 2004 Oct; 39(10):1031-2; author reply 1029-30. PubMed ID: 15513349
    [No Abstract]   [Full Text] [Related]  

  • 18. Outliving colorectal cancer.
    Barkun A; Flegel K
    CMAJ; 2007 Sep; 177(6):545, 547. PubMed ID: 17846432
    [No Abstract]   [Full Text] [Related]  

  • 19. Demanding evidence.
    Handler S
    Minn Med; 2004 Feb; 87(2):7. PubMed ID: 15005122
    [No Abstract]   [Full Text] [Related]  

  • 20. Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer (Br J Surg 2008; 95: 1029-1036).
    Corder AP; Iqbal M; Devaraj S
    Br J Surg; 2008 Nov; 95(11):1428-9; author reply 1429. PubMed ID: 18844282
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.